SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elroy who wrote (206)7/27/1999 6:44:00 PM
From: Stewart Elliot  Read Replies (1) of 211
 
So, what's your point? A/R is likely way up, which would explain the difference between the loss and the cash drain between 1st and 2nd quarters. Now, for a person who predicted $2MM in 2Q revenues on the yahoo board, you should be ecstatic that GSII exceeded that number by 40%. GSII unfortunately lost $3MM but legal expenses are clearly continuing. That's a bummer, but we're in this stock for growth, and GSII is suddenly showing it - and way beyond your own expectations. My guess is that operations are running at about $5MM a quarter, with legal making up the difference. If GSII can just hit $6MM by 4Q or 1Q, we'll see a break even quarter.

This is going to be a $10+ stock in the next 6-12 months, so it's a winner investment. I'd like to see it happen sooner, but this legal overhang looks like it will be around for at least another 6 months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext